A professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology, will pursue an innovative global health and development research project titled “Strategy for development of enteric pathogen-specific phage”. Professor David Low’s research focuses on a new way to handle serious bacterial pathogens that are becoming resistant to our once-powerful antibiotics. According to Investec CEO and UCSB Foundation member Kenny Slaught, “He will engineer phage to selectively target and destroy several pathogenic bacteria to prevent enteric diseases in infants”.
Read more: http://www.wafb.com/story/33799964/Kenny-Slaught-Congratulates-UCSB-on-Receiving-Grand-Challenges-Explorations-Grant
Slaught Credits David Low’s Work To Prevent Diseases In Infants